We provide you with 20 years of free, institutional-grade data for LYEL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LYEL. Explore the full financial landscape of LYEL stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-12 | 1806952 | LYEL | 10-Q | Url |
| 2025-05-13 | 1806952 | LYEL | 10-Q | Url |
| 2025-03-11 | 1806952 | LYEL | 10-K | Url |
| 2024-11-07 | 1806952 | LYEL | 10-Q | Url |
| 2024-08-07 | 1806952 | LYEL | 10-Q | Url |
| 2024-05-06 | 1806952 | LYEL | 10-Q | Url |
| 2024-02-28 | 1806952 | LYEL | 10-K | Url |
| 2023-11-07 | 1806952 | LYEL | 10-Q | Url |
| 2023-08-08 | 1806952 | LYEL | 10-Q | Url |
| 2023-05-04 | 1806952 | LYEL | 10-Q | Url |
| 2023-02-28 | 1806952 | LYEL | 10-K | Url |
| 2022-11-08 | 1806952 | LYEL | 10-Q | Url |
| 2022-08-04 | 1806952 | LYEL | 10-Q | Url |
| 2022-05-10 | 1806952 | LYEL | 10-Q | Url |
| 2022-03-29 | 1806952 | LYEL | 10-K | Url |
| 2021-11-12 | 1806952 | LYEL | 10-Q | Url |
| 2021-08-12 | 1806952 | LYEL | 10-Q | Url |
| 2021-05-25 | 1806952 | LYEL | S-1 | Url |
Lyell Immunopharma Inc(NASDAQ:LYEL) 
Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer. South San Francisco, California, United States.
Share this website to your friends
The information provided in this report about LYEL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.